Multifactorial genesis of pancreatitis in primary hyperparathyroidism: Evidence for protective (PRSS2) and destructive (CTRC) genetic factors

Experimental and Clinical Endocrinology and Diabetes

Volumn 119, Issue 1, 2011, Pages 26-29

  Felderbauer, P ^a   Karakas, E ^b   Fendrich, V ^b   Lebert, R ^a   Bartsch, D K ^b   Bulut, K ^a  

^a ST JOSEF HOSPITAL   (Germany)

^b UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

CTRC; hypercalcaemia; hyperparathyroidism; pancreatitis; PRSS2

Indexed keywords

CHYMOTRYPSIN; CHYMOTRYPSIN C; PROTECTIVE GENETIC VARIANTS EXIST IN THE ANIONIC TRYPSINOGEN GENE; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG;

ACUTE PANCREATITIS; ADULT; ARTICLE; CHRONIC PANCREATITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA SEQUENCE; FEMALE; GEL ELECTROPHORESIS; GENE; GENE MUTATION; GENETIC VARIABILITY; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MELTING POINT; MEMBRANE CONDUCTANCE; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; SERINE PROTEASE INHIBITOR KAZAL TYPE 1 GENE;

AGED; CHYMOTRYPSIN; DATABASES, FACTUAL; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MALE; MIDDLE AGED; PANCREATITIS; POLYMERASE CHAIN REACTION; TRYPSIN; TRYPSINOGEN;

EID: 78651456328     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0030-1255106     Document Type: Article

References (19)

1. Felderbauer P, Karakas E, Fendrich V, etal. Pancreatitis risk in primary hyperparathyroidism: Relation to mutations in the spink1 trypsin inhibitor (N34S) and the cystic fibrosis gene. Am J Gastroenterol 2008 103 368-374
2. Sutton R, Criddle D, Raraty MG, etal. Signal transduction, calcium and acute pancreatitis. Pancreatology 2003 3 497-505
3. Felderbauer P, Karakas E, Fendrich V, etal. Pancreatitis in primary hyperparathyroidism-related hypercalcaemia is not associated with mutations in the casr gene. Exp Clin Endocrinol Diabetes 2007 115 527-529
4. Rosendahl J, Witt H, Szmola R, etal. Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis. Nat Genet 2008 40 78-82
5. Rinderknecht H, Adham NF, Renner IG, etal. A possible zymogen self-destruct mechanism preventing pancreatic autodigestion. Int J Pancreatol 1988 3 33-44
6. Szmola R, Sahin-Toth M. Chymotrypsin C (caldecrin) promotes degradation of human cationic trypsin: Identity with rinderknecht's enzyme y. Proc Natl Acad Sci USA 2007 104 11227-11232
7. Tomomura A, Yamada H, Fujimoto K, etal. Determination of amino acid sequence responsible for suppression of bone resorption by serum calcium-decreasing factor (caldecrin). FEBS Lett 2001 508 454-458
8. Tomomura A, Fukushige T, Noda T, etal. Serum calcium-decreasing factor (caldecrin) from porcine pancreas has proteolytic activity which has no clear connection with the calcium decrease. FEBS Lett 1992 301 277-281
9. Tomomura A, Fukushige T, Tomomura M, etal. Caldecrin proform requires trypsin activation for the acquisition of serum calcium-decreasing activity. FEBS Lett 1993 335 213-216
10. Witt H, Sahin-Toth M, Landt O, etal. A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis. Nat Genet 2006 38 668-673
11. Etemad B, Whitcomb DC. Chronic pancreatitis: Diagnosis, classification, and new genetic developments. Gastroenterology 2001 120 682-707
12. Sahin-Toth M. Biochemical models of hereditary pancreatitis. Endocrinol Metab Clin North Am 2006 35 303-312 ix
13. Bess MA, Edis AJ, van Heerden JA. Hyperparathyroidism and pancreatitis. Chance or a causal association? JAMA 1980 243 246-247
14. van Lanschot JJ, Bruining HA. Primary hyperparathyroidism and pancreatitis. Neth J Surg 1984 36 38-41
15. Koppelberg T, Bartsch D, Printz H, etal. [pancreatitis in primary hyperparathyroidism (phpt) is a complication of advanced phpt]. Dtsch Med Wochenschr 1994 119 719-724
16. Carnaille B, Oudar C, Pattou F, etal. Pancreatitis and primary hyperparathyroidism: Forty cases. Aust N Z J Surg 1998 68 117-119
17. Agarwal A, George RK, Gupta SK, etal. Pancreatitis in patients with primary hyperparathyroidism. Indian J Gastroenterol 2003 22 224-225
18. Sherwood MW, Prior IA, Voronina SG, etal. Activation of trypsinogen in large endocytic vacuoles of pancreatic acinar cells. Proc Natl Acad Sci USA 2007 104 5674-5679
19. Santhosh S, Witt H, te Morsche RH, etal. A loss of function polymorphism (G191R) of anionic trypsinogen (PRSS2) confers protection against chronic pancreatitis. Pancreas 2008 36 317-320